Author:
Bertini R,Barcelos LS,Beccari AR,Cavalieri B,Moriconi A,Bizzarri C,Di Benedetto P,Di Giacinto C,Gloaguen I,Galliera E,Corsi MM,Russo RC,Andrade SP,Cesta MC,Nano G,Aramini A,Cutrin JC,Locati M,Allegretti M,Teixeira MM
Reference69 articles.
1. Liver ischemia/reperfusion injury: processes in inflammatory networks - a review;Abu-Amara;Liver Transpl,2010
2. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity;Addison;J Immunol,2000
3. The CXC chemokines growth-related oncogene (Gro)alpha, GRO beta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor;Ahuja;J Biol Chem,1996
4. Allosteric inhibitors of chemoattractant receptors: opportunities and pitfalls;Allegretti;Trends Pharmacol Sci,2008
5. Chemokines in inflammation and immunity;Baggiolini;Immunol Today,2000
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献